Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
12 Jun 24 | BPMC Blueprint Medicines | Common Stock | Grant | Acquire A | No | No | 0 | 2,242 | 0.00 | 18,254 |
12 Jun 24 | BPMC Blueprint Medicines | Stock Option Common Stock | Grant | Acquire A | No | No | 106.14 | 4,570 | 485.06 k | 4,570 |
1 May 24 | GLYC GlycoMimetics | Stock Option Common Stock | Grant | Acquire A | No | No | 1.62 | 40,000 | 64.80 k | 40,000 |
29 Mar 24 | GLYC GlycoMimetics | Common Stock | Grant | Acquire A | No | No | 3 | 4,584 | 13.75 k | 24,828 |
12 Feb 24 | IMGN Immunogen | Common Stock | Sale back to company | Dispose D | No | No | 0 | 60,720 | 0.00 | 0 |
12 Feb 24 | IMGN Immunogen | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 17.72 | 19,597 | 347.26 k | 0 |
12 Feb 24 | IMGN Immunogen | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 3.37 | 44,000 | 148.28 k | 0 |
12 Feb 24 | IMGN Immunogen | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 6.77 | 44,000 | 297.88 k | 0 |
12 Feb 24 | IMGN Immunogen | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 4.56 | 50,000 | 228.00 k | 0 |
12 Feb 24 | IMGN Immunogen | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 2.1 | 18,000 | 37.80 k | 0 |